Wei Shi
Dr Shi is a molecular and cell biologist with experience in high throughput functional assays. She has published 35 papers (6 in the last five years) in journals such as Nature Genetics, Blood, PLoS Genetics, American Journal of Human Genetics and Cell Research. She has an interest in characterizing gene function and genetic regulation of functional genes using cellular models, patient-derived xenograft, transgenic mouse models and high throughput functional screens. She led the medium-throughput validation of candidate breast cancer risk genes identified using the first transcriptome-wide association study (TWAS) of cancer. In 2021, she was re-appointed as research officer in the Genome Variation and Regulation team under the supervision of Dr Jonathan Beesley. Previously, Shi also worked in the Cancer Genetics Laboratory and Signal Transduction laboratory in QIMRB. Before joining QIMRB Shi completed a 3-year postdoc in Washington University in St. Louis studying DNA repair pathways. Shi began her career working in Public Health and Medicine in China.
Abstracts this author is presenting: